RecruitingNCT06697964

High Resolution Anuscopy Study


Sponsor

Universitair Ziekenhuis Brussel

Enrollment

500 participants

Start Date

Aug 8, 2024

Study Type

OBSERVATIONAL

Conditions

Summary

The majority of anal squamous cell carcinomas (SCC) stem from infection with high-risk human papillomavirus (HPV). Anal SCC is rare among the general population but affects several populations disproportionately. High-risk groups are screened through anal swabs for anal cytology and detection of high risk human papillomavirus (HR HPV). HRA referral is recommended for individuals with abnormal cytology. HRA represents the only method to identify precancerous lesions of the anal canal, with only few specialists knowledgeable about it. At UZ Brussel, the investigators collected a wealth of data about HPV infection and its association with anal pathology. By establishing a comprehensive study, the investigators can delve into this data with specific research questions, conducting valuable research to provide answers to pressing clinical questions and contribute to advancements in medical understanding and treatment.


Eligibility

Min Age: 18 Years

Inclusion Criteria3

  • All patients who have undergone HRA and all future patients referred for HRA in UZ Brussel
  • years or older
  • Understands and able to speak and write in French, Dutch or English

Exclusion Criteria1

  • None

Interventions

OTHERHRA

High resolution anoscopy to help evaluate anal conditions such as precancerous lesions


Locations(1)

UZ Brussel

Jette, Belgium

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06697964


Related Trials